Journals / Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi / 2019 / Cilt: 23 - Sayı: 2

Determination of Deleterious SNPs in APH1A Gene Related to Alzheimer’s Disease by In Silico Methods

Alzheimer Hastalığı ile İlişkilendirilen APH1A Genindeki Zararlı SNP’lerin In Silico Yöntemler ile Belirlenmesi

Pages
472–480
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results showed that 257 SNPs among a total of 3567 SNPs in the APH1A gene were missense SNPs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by pathological accumulation of β-amyloid (Aβ) senile plaques and neurofibrillary tangles. γ-secretase produces the amyloid β peptide (Aβ), which causes AD. γ-secretase is a macromolecular complex and the protein encoded by the APH1A gene is located in this complex.
📊
Key Findings & Data:In this study, it was aimed to determine the possible deleterious effects of missense single nucleotide polymorphisms (SNPs) in APH1A gene on the protein structure and stabilization via in silico methods.
💡
Conclusion & Impact:The results showed that 257 SNPs among a total of 3567 SNPs in the APH1A gene were missense SNPs.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:APH1A · Polimorfizm · Alzheimer Hastalığı

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by pathological accumulation of β-amyloid (Aβ) senile plaques and neurofibrillary tangles. γ-secretase produces the amyloid β peptide (Aβ), which causes AD. γ-secretase is a macromolecular complex and the protein encoded by the APH1A gene is located in this complex. In this study, it was aimed to determine the possible deleterious effects of missense single nucleotide polymorphisms (SNPs) in APH1A gene on the protein structure and stabilization via in silico methods. PolyPhen-2 and SIFT were used to predict deleterious SNPs, I-Mutant 2.0 software was used to detect protein stabilization changes and Project HOPE software tool was used to make three-dimensional modeling of wild and mutant type proteins. The results showed that 257 SNPs among a total of 3567 SNPs in the APH1A gene were missense SNPs. According to the in silico analysis of the 257 SNPs it has been determined that rs11548266, rs74126634, rs145324799, rs199961673, rs370361277, rs370719475 and rs376071112 polymorphisms may have deleterious effects. The results of in silico analysis provide data for genotyping of SNPs which have deleterious effects on protein structure and stabilization rather than genotyping of entire 3567 SNPs in the APH1A gene associated with Alzheimer's disease. Therefore, deleterious SNPs may be used in the selection of SNPs and experimental design which are the most important stages of genotyping studies. Thus, we envisaged that the obtained results will contribute to the further studies either experimental or in silico on Alzheimer's disease.

Özet

Alzheimer hastalığı (AH), β-amiloid (Aβ) senil plakların ve nörofibriler yumakların patolojik birikimi ile karakterize olan ilerleyici bir nörodejeneratif hastalıktır. γ-sekretaz, AH nedeni olan amiloid β peptidi (Aβ) üretmektedir. γ-sekretaz makromoleküler bir komplekstir ve APH1A geninin kodladığı protein bu komplekste yer almaktadır. Bu çalışmada, APH1A genindeki yanlış anlamlı (missense) tek nükleotid polimorfizmlerinin (SNP) proteinin yapısı ve stabilizasyonu üzerindeki olası zararlı etkilerinin in silico yöntemler kullanılarak belirlenmesi amaçlanmıştır. Zararlı SNP’lerin tahmin edilmesi için PolyPhen-2 ve SIFT yazılım araçları, protein stabilizasyonu değişimlerinin tespit edilmesi için I-Mutant 2.0 yazılımı, yabanıl ve mutant tip proteinlerin üç boyutlu modellemeleri için Project HOPE yazılım aracı kullanılmıştır. Sonuçlar, APH1A geninde yer alan toplam 3567 SNP’nin 257 tanesinin yanlış anlamlı SNP olduğunu göstermiştir. 257 SNP’nin in silico analizlerine göre, rs11548266, rs74126634, rs145324799, rs199961673, rs370361277, rs370719475 ve rs376071112 polimorfizmlerinin zararlı etkilerinin olabileceği belirlenmiştir. Çalışmamızda gerçekleştirdiğimiz in silico analizler, Alzheimer hastalığı ile ilgili APH1A geninde yer alan 3567 SNP’nin tamamının genotiplenmesi yerine proteinin yapısı ve stabilizasyonuna zararlı etkisi olabilecek SNP’lerin genotiplenmesine ilişkin veri sağlamaktadır. Dolayısıyla, zararlı olduğu tespit edilen SNP’ler genotipleme çalışmalarının en önemli basamağı olan SNP seçiminde ve deney tasarımında kullanılabilecektir. Bu nedenle, elde ettiğimiz sonuçların Alzheimer hastalığı ile ilgili gelecekte yapılacak olan hem deneysel hem de in silico çalışmalara katkı sağlayacağı düşünülmektedir.

🔖

Cite This Article

OKTAY, E. Ö., KAMAN, T., KARASAKAL, Ö. F., ULUCAN, K., KONUK, M., TARHAN, N. (2019). Determination of Deleterious SNPs in APH1A Gene Related to Alzheimer’s Disease by In Silico Methods. Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi, Cilt: 23 - Sayı: 2, 472–480. https://ajindex.com/articles/309995

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. El Halawany AM, Sayed NSE, Abdallah HM, El Dine RS. 2017. Protective effects of gingerol on streptozotocin-induced sporadic Alzheimer’s disease: emphasis on inhibition of β-amyloid, COX-2, alpha-, beta-secretases and APH1a. Scientific Reports. 7(1):2902
  2. Iqbal K, Grundke-Iqbal I. 2010. Alzheimer's disease, a multifactorial disorder seeking multitherapies. Alzheimer's & Dementia: Elsevier; 420-424
  3. Yonemura Y, Futai E, Yagishita S, Kaether C, Ishiura S. 2016. Specific combinations of presenilins and Aph1s affect the substrate specificity and activity of γ-secretase. Biochemical and biophysical research communications.478(4):1751-1757
  4. De Strooper B. 2003. Aph-1, Pen-2, and nicastrin with presenilin generate an active γ-secretase complex. Neuron. 38(1):9-12
  5. Gertsik N, Chiu D, LI Y. 2015. Complex regulation of gamma-secretase: from obligatory to modulatory subunits. Frontiers in aging neuroscience. 6:342
  6. Hur J-Y, Gertsik N, Johnson D, Li Y-M. 2016. γ-Secretase Inhibitors: From Chemical Probes to Drug Development. Developing Therapeutics for Alzheimer's Disease: Elsevier; 63-76
  7. Lee S-F, Shah S, Li H, Yu C, Han W, Yu G. 2002. Mammalian APH-1 interacts with presenilin and nicastrin and is required for intramembrane proteolysis of amyloid-β precursor protein and Notch. Journal of Biological Chemistry. 277(47):45013-45019
  8. Takasugi N, Tomita T, Hayashi I, et al. 2003. The role of presenilin cofactors in the γ-secretase complex. Nature. 422(6930):438
  9. Haapasalo A, Kovacs DM. 2011. The many substrates of presenilin/γ-secretase. Journal of Alzheimer's disease.25(1):3-28
  10. Mohandas E, Rajmohan V, Raghunath B. 2009. Neurobiology of Alzheimer's disease. Indian journal of psychiatry. 51(1):55
  11. Hemming ML, Selkoe DJ. 2005. Amyloid β-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. Journal of Biological Chemistry. 280(45):37644-37650
  12. Zhang Y, McLaughlin R, Goodyer C, LeBlanc A. 2002. Selective cytotoxicity of intracellular amyloid β peptide1–42 through p53 and Bax in cultured primary human neurons. The Journal of cell biology. 156(3):519-529
  13. Özkay ÜD, Öztürk Y, Can ÖD. 2011. Yaşlanan dünyanın hastalığı: Alzheimer hastalığı. SDÜ Tıp Fakültesi Dergisi.18(1):35-42
  14. Reddy PH, Beal MF. 2008. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends in molecular medicine.14(2):45-53. [